ShreeOswal Seeds And Chemicals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
OSWALSEEDS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
ShreeOswal Seeds and Chemicals Limited reported its Q3 FY26 and 9M FY26 results with an unmodified auditor opinion from H Sahu & Co. On a standalone basis, Q3 revenue from operations stood at Rs. 3,356.54 lacs, broadly flat versus Rs. 3,771.38 lacs in Q3 FY25, while standalone PAT came in at Rs. 111.08 lacs versus Rs. 109.23 lacs a year ago. On a consolidated basis (which includes subsidiary ShreeOswal Psyllium Exports India Limited), Q3 revenue dropped sharply to Rs. 5,475.31 lacs from Rs. 7,542.36 lacs in Q3 FY25, a decline of about 27%. However, 9M FY26 consolidated PAT jumped to Rs. 511.35 lacs from Rs. 297.46 lacs in 9M FY25, a rise of nearly 72%, supported by a turnaround in the Seeds division.
Mixed picture for shareholders: the Seeds division is performing well (Q3 segment profit up to Rs. 178.31 lacs from Rs. 118.29 lacs), but the Psyllium division saw segment profit collapse from Rs. 682.21 lacs to Rs. 81.39 lacs in Q3, dragging consolidated top-line. Investors should watch whether the Psyllium weakness is a temporary blip or a structural concern, while the standalone stability offers some comfort.